Amlodipine Besylate; Indapamide; Telmisartan Patent Expiration
Amlodipine Besylate; Indapamide; Telmisartan was first introduced by Azurity Pharmaceuticals Inc
Amlodipine Besylate; Indapamide; Telmisartan Patents
Given below is the list of patents protecting Amlodipine Besylate; Indapamide; Telmisartan, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Widaplik | US10322117 | Compositions for the treatment of hypertension | Jan 23, 2038 | Azurity |
| Widaplik | US10799487 | Compositions for the treatment of hypertension | Jan 23, 2038 | Azurity |
Amlodipine Besylate; Indapamide; Telmisartan's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List